Obesity-related asthma: new insights leading to a different approach

Adjan Witte, Yasemin Türk, Gert-Jan Braunstahl

Research output: Contribution to journalArticleAcademicpeer-review


PURPOSE OF REVIEW: Obesity is a growing global health threat that significantly contributes to the burden of asthma by increasing the risk of developing asthma and exerting a distinct effect on lung function and inflammation. The treatment of obesity-related asthma is hindered by a poor response to standard asthma treatments, leading to worse asthma control. Weight loss strategies have a significant effect on asthma symptoms but are not feasible for a large proportion of patients, underscoring the need for a better understanding of the pathophysiology and the development of additional treatment options.

RECENT FINDINGS: Recent literature focusing on pathophysiology particularly delved into nontype 2 inflammatory mechanisms, associations with the metabolic syndrome and small airway impairment. Additionally, several new treatment options are currently investigated, including biologics, weight reduction interventions, and novel antiobesity drugs.

SUMMARY: Obesity-related asthma is a highly prevalent asthma phenotype for which weight loss strategies currently stand as the most specific treatment. Furthermore, novel pharmacological interventions aiming at metabolic processes are on the way.

Original languageEnglish
Pages (from-to)294-302
Number of pages9
JournalCurrent Opinion in Pulmonary Medicine
Issue number3
Early online date5 Mar 2024
Publication statusPublished - 1 May 2024

Bibliographical note

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.


Dive into the research topics of 'Obesity-related asthma: new insights leading to a different approach'. Together they form a unique fingerprint.

Cite this